查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2035822

2026年全球人工智慧（AI）和生物計算大型模型市場報告

Artificial Intelligence (AI) Biocomputing Big Model Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基於人工智慧（AI）的大型生物計算模型市場規模呈現爆炸性成長。預計該市場將從2025年的43.8億美元成長到2026年的52.9億美元，複合年成長率（CAGR）為20.6%。過去幾年的成長主要歸功於基因組學和蛋白​​質組學研究的進步、計算生物學參與度的提高、深度學習框架的應用、製藥和生物技術領域研發投入的增加，以及對分子相互作用預測日益成長的需求。

預計未來幾年人工智慧（AI）生物計算大型模型市場將大幅成長，到2030年將達到112.7億美元，複合年成長率（CAGR）為20.8%。預測期內的成長要素包括混合AI生物運算系統的廣泛應用、個人化醫療應用需求的成長、大規模生物模型的廣泛應用、雲端生物資訊服務的擴展以及與醫療和農業數據整合技術的進步。預測期內的關鍵趨勢包括雲端生物資訊學平台的廣泛應用、對高效能運算硬體需求的成長、多組體學資料分析工具整合技術的進步、模擬數位雙胞胎軟體應用的擴展以及對AI生物運算相關培訓和教育服務的日益關注。

未來幾年，對個人化醫療日益成長的需求預計將推動人工智慧（AI）生物計算大型模型市場的擴張。個人化醫療是指根據個人的基因、分子和臨床特徵量身訂做醫療干預措施。基因組學和其他高通量生物技術的進步顯著增加了患者數據的數量和複雜性，需要複雜的計算方法才能從中獲得具有臨床意義的見解。人工智慧生物計算大型模型是能夠處理基因組學、蛋白質組學、醫學影像和電子健康記錄等多模態資料集的大規模人工智慧系統，透過大規模地進行疾病風險預測、治療最佳化和治療方法客製化，為個人化醫療提供支援。例如，根據總部位於美國的非營利組織個人化醫療聯盟的報告，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的新型個人化治療方法，高於2022年的6種。因此，對個人化醫療日益成長的需求正在推動人工智慧（AI）生物計算大模型市場的成長。

預計藥物研發投入的擴大將推動人工智慧生物運算巨量資料模型市場的成長。藥物研發涵蓋製藥公司、生技公司和研究機構為發現、開發和改進新治療方法而進行的系統性工作。藥物研發投入的增加源於提高藥物發現效率、縮短研發週期以及應對複雜疾病的需求，這也導致對先進計算技術的依賴性增強。人工智慧生物計算巨量資料模型在藥物研發中發揮著至關重要的作用，能夠對多組體學數據、分子結構、臨床試驗資訊和真實世界數據進行大規模分析。這些模型有助於標靶識別、先導化合物最佳化、毒性預測和患者分層，進而提升整個藥物開發平臺中的決策水準。例如，根據英國國家統計局的數據，英國政府2023年研發淨支出從2022年的161億英鎊（204.5億美元）增加至174億英鎊（221億美元），增幅達8.2%。因此，研發活動的擴張正在推動人工智慧生物計算大型模型市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球人工智慧（AI）生物計算大型模型市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 人工智慧和自主智慧
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 擴展客製化資料擷取解決方案，以滿足小眾資料需求。
  • 主要趨勢
    • 雲端生物資訊平台的日益普及
    • 高效能運算硬體的需求日益成長
    • 多體學資料分析工具的整合正在逐步推進。
    • 模擬數位雙胞胎軟體的應用領域不斷擴展
    • 人們對人工智慧生物計算的培訓和教育服務越來越感興趣。

第5章 終端用戶產業市場分析

  • 製藥和生物技術公司
  • 研究機構和學術界
  • 醫療服務提供方
  • 農業相關企業
  • 政府附屬研究機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球人工智慧（AI）生物計算大型模型市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球人工智慧（AI）生物計算大型模型市場：規模、對比及成長率分析
  • 全球人工智慧（AI）生物計算大型模型市場表現：規模與成長，2020-2025年
  • 全球人工智慧（AI）生物計算大型模型市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按組件
  • 硬體、軟體、服務
  • 特定型號
  • 大規模生物模型、深度學習架構、生物資訊平台、模擬與數位雙胞胎軟體
  • 部署模式
  • 本機部署、雲端部署、混合式部署
  • 透過使用
  • 基因測序、蛋白質結構預測及其他應用
  • 按最終用戶行業分類
  • 製藥和生物技術公司、研究和學術機構、醫療保健提供者、農業公司、環境和自然保護組織以及政府研究機構。
  • 細分：依類型：硬體
  • 處理器、圖形處理單元、高效能運算系統、資料儲存系統、網路與互連設備、人工智慧加速器、生物資訊工作站
  • 細分：依類型：軟體
  • 模型開發和訓練軟體、生物資訊分析軟體、模擬和建模軟體、資料管理和整合軟體、視覺化和解釋軟體、工作流程和流程管理軟體
  • 細分：依類型：服務
  • 諮詢和策略服務、系統整合服務、雲端實施和基礎設施服務、技術支援和維護服務、數據分析和模型最佳化服務、培訓和教育服務

第10章 市場與產業指標：依國家分類

第11章 區域與國別分析

第12章 亞太市場

第13章：中國市場

第14章：印度市場

第15章：日本市場

第16章：澳洲市場

第17章：印尼市場

第18章：韓國市場

第19章 台灣市場

第20章：東南亞市場

第21章 西歐市場

第22章英國市場

第23章：德國市場

第24章：法國市場

第25章：義大利市場

第26章：西班牙市場

第27章 東歐市場

第28章：俄羅斯市場

第29章 北美市場

第30章：美國市場

第31章：加拿大市場

第32章：南美洲市場

第33章：巴西市場

第34章 中東市場

第35章：非洲市場

第36章 市場監理與投資環境

第37章：競爭格局與公司概況

  • 人工智慧（AI）生物計算大型模型市場：競爭格局和市場佔有率，2024 年
  • 人工智慧（AI）生物計算大型模型市場：公司估值矩陣
  • 人工智慧（AI）生物計算大型模型市場：公司概況
    • Microsoft Corporation
    • Alibaba Group Holding Limited
    • Huawei Technologies Co. Ltd.
    • Siemens AG
    • International Business Machines Corporation

第38章 其他大型企業和創新企業

  • Oracle Corporation, Nvidia Corporation, Generate Biomedicines Inc., Owkin Inc., Nabla Bio Inc., Arzeda Corp., Evozyne Inc., BigHat Biosciences Inc., AI Proteins Inc., Cradle BV, Profluent Bio Inc., Absci Corporation, Biomatter Designs UAB, Insilico Medicine Ltd., Variant Bio Inc.

第39章 全球市場競爭基準分析與儀錶板

第40章：預計進入市場的新創企業

第41章 重大併購

第42章 具有高市場潛力的國家、細分市場與策略

  • 2030年人工智慧（AI）生物計算大型模型市場：提供新機會的國家
  • 2030年人工智慧（AI）生物運算大型模型市場：提供新機會的細分市場
  • 2030年人工智慧（AI）生物計算大型模型市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第43章附錄

簡介目錄
Product Code: IT4MAIAB10_G26Q2

An artificial intelligence (AI) biocomputing big model is a large-scale AI system designed to analyze complex biological and biomedical data, including genomics, proteomics, and multi-omics datasets. It uses deep learning and generative modeling to predict molecular interactions, identify biomarkers, and support applications such as personalized medicine and drug discovery.

The primary components of artificial intelligence biocomputing big model include hardware, software, and services. Hardware includes high-performance computing systems and processors used to support complex biological data analysis and large-scale model training. These solutions incorporate models such as large biological models, deep learning frameworks, bioinformatics platforms, and simulation and digital twin software. Deployment occurs through on-premises, cloud-based, and hybrid models. Applications include genome sequencing, protein structure prediction, and other areas, serving end users such as pharmaceutical and biotechnology companies, research institutions and academia, healthcare providers, agricultural firms, environmental and conservation organizations, and government research labs.

Tariffs on imported high-performance computing hardware, AI accelerators, and specialized bioinformatics equipment are impacting the AI biocomputing big model market by increasing production and deployment costs, particularly affecting hardware and cloud deployment segments. Regions such as North America, Europe, and Asia-Pacific, which rely on imported servers, GPUs, and data storage systems, are most affected. While tariffs raise costs, they also encourage local manufacturing, drive regional innovation in cost-efficient AI hardware, and promote domestic service providers, supporting long-term market resilience and self-reliance.

The artificial intelligence (AI) biocomputing big model market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) biocomputing big model market statistics, including artificial intelligence (AI) biocomputing big model industry global market size, regional shares, competitors with a artificial intelligence (AI) biocomputing big model market share, detailed artificial intelligence (AI) biocomputing big model market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) biocomputing big model industry. This artificial intelligence (AI) biocomputing big model market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI) biocomputing big model market size has grown exponentially in recent years. It will grow from $4.38 billion in 2025 to $5.29 billion in 2026 at a compound annual growth rate (CAGR) of 20.6%. The growth in the historic period can be attributed to growth in genomics and proteomics research, increasing computational biology initiatives, adoption of deep learning frameworks, expansion of pharmaceutical and biotech R&D, rising need for molecular interaction prediction.

The artificial intelligence (AI) biocomputing big model market size is expected to see exponential growth in the next few years. It will grow to $11.27 billion in 2030 at a compound annual growth rate (CAGR) of 20.8%. The growth in the forecast period can be attributed to increasing deployment of hybrid AI biocomputing systems, growing demand for personalized medicine applications, rising adoption of large biological models, expansion of cloud-based bioinformatics services, increasing integration with healthcare and agricultural data. Major trends in the forecast period include increasing adoption of cloud-based bioinformatics platforms, rising demand for high-performance computing hardware, growing integration of multi-omics data analysis tools, expansion of simulation and digital twin software applications, rising focus on training and education services for ai biocomputing.

The increasing demand for personalized medicine is anticipated to fuel the expansion of the artificial intelligence (AI) biocomputing big model market in the coming years. Personalized medicine refers to customizing healthcare interventions according to an individual's genetic, molecular, and clinical attributes. Progress in genomic and other high-throughput biological technologies has substantially expanded the volume and complexity of patient data, generating a requirement for advanced computational methods to derive clinically meaningful insights. AI biocomputing big models are large-scale AI systems capable of processing multi-modal datasets such as genomics, proteomics, medical imaging, and electronic health records, supporting personalized medicine by facilitating disease risk prediction, treatment optimization, and therapy customization at scale. For example, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the US Food and Drug Administration approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Therefore, the rising demand for personalized medicine is propelling the growth of the artificial intelligence (AI) biocomputing big model market.

The expansion of pharmaceutical research and development (R&D) initiatives is projected to stimulate the growth of the AI biocomputing big model market. Pharmaceutical R&D encompasses structured efforts by drug manufacturers, biotechnology firms, and research organizations to discover, develop, and refine new therapies. Growing investment in pharmaceutical R&D is driven by the necessity to enhance drug discovery efficiency, shorten development timelines, and tackle complex diseases, thereby heightening reliance on advanced computational technologies. AI biocomputing big models serve a vital function in pharmaceutical R&D by facilitating large-scale analysis of multi-omics data, molecular structures, clinical trial information, and real-world evidence. These models assist in target identification, lead optimization, toxicity forecasting, and patient stratification, thereby strengthening decision-making throughout the drug development pipeline. For example, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government's net spending on research and development rose to £17.4 billion ($22.1 billion), compared with £16.1 billion ($20.45 billion) in 2022, marking an 8.2% increase. Therefore, the growth in research and development activities is driving the expansion of the AI biocomputing big model market.

The expanding use of health monitoring devices is expected to accelerate the growth of the AI biocomputing big model market in the foreseeable future. Health monitoring devices are medical or wearable technologies intended to continuously or periodically gather and evaluate physiological data to determine an individual's health condition and support timely medical care. The rising adoption of health monitoring devices is fueled by the increasing prevalence of chronic diseases, as continuous real-time tracking allows early intervention, improved disease management, and lower hospitalization rates. AI biocomputing big models strengthen health monitoring devices by processing large-scale, multi-parameter physiological data in real time to identify subtle patterns, forecast health risks, deliver personalized insights, and enable proactive, precision-focused interventions. For example, in August 2025, as reported by the Office of Inspector General, a US-based independent organization, the number of Medicare beneficiaries utilizing remote patient monitoring grew substantially, reaching nearly 1 million in 2024, representing a 27% increase compared to 2023. Therefore, the increasing adoption of health monitoring devices is propelling the growth of the AI biocomputing big model market.

Major companies operating in the artificial intelligence (AI) biocomputing big model market are Microsoft Corporation, Alibaba Group Holding Limited, Huawei Technologies Co. Ltd., Siemens AG, International Business Machines Corporation, Oracle Corporation, Nvidia Corporation, Generate Biomedicines Inc., Owkin Inc., Nabla Bio Inc., Arzeda Corp., Evozyne Inc., BigHat Biosciences Inc., AI Proteins Inc., Cradle B.V., Profluent Bio Inc., Absci Corporation, Biomatter Designs UAB, Insilico Medicine Ltd., and Variant Bio Inc.

North America was the largest region in the artificial intelligence (AI) biocomputing big model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) biocomputing big model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) biocomputing big model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI) biocomputing big model market includes revenues earned by entities providing services such as model training and fine-tuning, cloud-based model hosting and inference, custom model development, and integration into enterprise or research workflows. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The artificial intelligence (AI) biocomputing big model market consists of sales of products such as large-scale biological foundation models, genomic and proteomic prediction engines, molecular simulation AI systems, drug discovery models, and multimodal bio-AI models. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) Biocomputing Big Model Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial intelligence (ai) biocomputing big model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) biocomputing big model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai) biocomputing big model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Hardware; Software; Services
  • 2) By Model: Large Biological Models; Deep Learning Frameworks; Bioinformatics Platforms; Simulation And Digital Twin Software
  • 3) By Deployment Mode: On-Premise; Cloud-Based; Hybrid
  • 4) By Application: Genome Sequencing; Protein Structure Prediction; Other Applications
  • 5) By End-User Industry: Pharmaceutical And Biotechnology; Research Institutions And Academia; Healthcare Providers; Agricultural Firms; Environmental And Conservation Organizations; Government Research Labs
  • Subsegments:
  • 1) By Hardware: Processors; Graphics Processing Units; High Performance Computing Systems; Data Storage Systems; Networking And Interconnect Equipment; Artificial Intelligence Accelerators; Bioinformatics Workstations
  • 2) By Software: Model Development And Training Software; Bioinformatics Analysis Software; Simulation And Modeling Software; Data Management And Integration Software; Visualization And Interpretation Software; Workflow And Pipeline Management Software
  • 3) By Services: Consulting And Strategy Services; System Integration Services; Cloud Deployment And Infrastructure Services; Technical Support And Maintenance Services; Data Analysis And Model Optimization Services; Training And Education Services
  • Companies Mentioned: Microsoft Corporation; Alibaba Group Holding Limited; Huawei Technologies Co. Ltd.; Siemens AG; International Business Machines Corporation; Oracle Corporation; Nvidia Corporation; Generate Biomedicines Inc.; Owkin Inc.; Nabla Bio Inc.; Arzeda Corp.; Evozyne Inc.; BigHat Biosciences Inc.; AI Proteins Inc.; Cradle B.V.; Profluent Bio Inc.; Absci Corporation; Biomatter Designs UAB; Insilico Medicine Ltd.; and Variant Bio Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Intelligence (AI) Biocomputing Big Model Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Intelligence (AI) Biocomputing Big Model Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Intelligence (AI) Biocomputing Big Model Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Intelligence (AI) Biocomputing Big Model Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption of Cloud-Based Bioinformatics Platforms
    • 4.2.2 Rising Demand for High-Performance Computing Hardware
    • 4.2.3 Growing Integration of Multi-Omics Data Analysis Tools
    • 4.2.4 Expansion of Simulation and Digital Twin Software Applications
    • 4.2.5 Rising Focus on Training and Education Services for AI Biocomputing

5. Artificial Intelligence (AI) Biocomputing Big Model Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnology Firms
  • 5.2 Research Institutions And Academia
  • 5.3 Healthcare Providers
  • 5.4 Agricultural Firms
  • 5.5 Government Research Labs

6. Artificial Intelligence (AI) Biocomputing Big Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Intelligence (AI) Biocomputing Big Model Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Intelligence (AI) Biocomputing Big Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Intelligence (AI) Biocomputing Big Model Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Intelligence (AI) Biocomputing Big Model Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Intelligence (AI) Biocomputing Big Model Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Intelligence (AI) Biocomputing Big Model Market Segmentation

  • 9.1. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hardware, Software, Services
  • 9.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Model, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Large Biological Models, Deep Learning Frameworks, Bioinformatics Platforms, Simulation And Digital Twin Software
  • 9.3. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • On-Premise, Cloud-Based, Hybrid
  • 9.4. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Genome Sequencing, Protein Structure Prediction, Other Applications
  • 9.5. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By End-User Industry, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnology, Research Institutions And Academia, Healthcare Providers, Agricultural Firms, Environmental And Conservation Organizations, Government Research Labs
  • 9.6. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Processors, Graphics Processing Units, High Performance Computing Systems, Data Storage Systems, Networking And Interconnect Equipment, Artificial Intelligence Accelerators, Bioinformatics Workstations
  • 9.7. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Model Development And Training Software, Bioinformatics Analysis Software, Simulation And Modeling Software, Data Management And Integration Software, Visualization And Interpretation Software, Workflow And Pipeline Management Software
  • 9.8. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting And Strategy Services, System Integration Services, Cloud Deployment And Infrastructure Services, Technical Support And Maintenance Services, Data Analysis And Model Optimization Services, Training And Education Services

10. Artificial Intelligence (AI) Biocomputing Big Model Market, Industry Metrics By Country

  • 10.1. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Artificial Intelligence (AI) Biocomputing Big Model Market Regional And Country Analysis

  • 11.1. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global Artificial Intelligence (AI) Biocomputing Big Model Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Artificial Intelligence (AI) Biocomputing Big Model Market

  • 12.1. Asia-Pacific Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Artificial Intelligence (AI) Biocomputing Big Model Market

  • 13.1. China Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Artificial Intelligence (AI) Biocomputing Big Model Market

  • 14.1. India Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Artificial Intelligence (AI) Biocomputing Big Model Market

  • 15.1. Japan Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 16.1. Australia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 17.1. Indonesia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Artificial Intelligence (AI) Biocomputing Big Model Market

  • 18.1. South Korea Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Artificial Intelligence (AI) Biocomputing Big Model Market

  • 19.1. Taiwan Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 20.1. South East Asia Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Artificial Intelligence (AI) Biocomputing Big Model Market

  • 21.1. Western Europe Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Artificial Intelligence (AI) Biocomputing Big Model Market

  • 22.1. UK Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Artificial Intelligence (AI) Biocomputing Big Model Market

  • 23.1. Germany Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Artificial Intelligence (AI) Biocomputing Big Model Market

  • 24.1. France Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Artificial Intelligence (AI) Biocomputing Big Model Market

  • 25.1. Italy Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Artificial Intelligence (AI) Biocomputing Big Model Market

  • 26.1. Spain Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Artificial Intelligence (AI) Biocomputing Big Model Market

  • 27.1. Eastern Europe Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Artificial Intelligence (AI) Biocomputing Big Model Market

  • 28.1. Russia Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Artificial Intelligence (AI) Biocomputing Big Model Market

  • 29.1. North America Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Artificial Intelligence (AI) Biocomputing Big Model Market

  • 30.1. USA Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Artificial Intelligence (AI) Biocomputing Big Model Market

  • 31.1. Canada Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Artificial Intelligence (AI) Biocomputing Big Model Market

  • 32.1. South America Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Artificial Intelligence (AI) Biocomputing Big Model Market

  • 33.1. Brazil Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Artificial Intelligence (AI) Biocomputing Big Model Market

  • 34.1. Middle East Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Artificial Intelligence (AI) Biocomputing Big Model Market

  • 35.1. Africa Artificial Intelligence (AI) Biocomputing Big Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa Artificial Intelligence (AI) Biocomputing Big Model Market, Segmentation By Component, Segmentation By Model, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Artificial Intelligence (AI) Biocomputing Big Model Market Regulatory and Investment Landscape

37. Artificial Intelligence (AI) Biocomputing Big Model Market Competitive Landscape And Company Profiles

  • 37.1. Artificial Intelligence (AI) Biocomputing Big Model Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. Artificial Intelligence (AI) Biocomputing Big Model Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. Artificial Intelligence (AI) Biocomputing Big Model Market Company Profiles
    • 37.3.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.2. Alibaba Group Holding Limited Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.3. Huawei Technologies Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.4. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 37.3.5. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis

38. Artificial Intelligence (AI) Biocomputing Big Model Market Other Major And Innovative Companies

  • Oracle Corporation, Nvidia Corporation, Generate Biomedicines Inc., Owkin Inc., Nabla Bio Inc., Arzeda Corp., Evozyne Inc., BigHat Biosciences Inc., AI Proteins Inc., Cradle B.V., Profluent Bio Inc., Absci Corporation, Biomatter Designs UAB, Insilico Medicine Ltd., Variant Bio Inc.

39. Global Artificial Intelligence (AI) Biocomputing Big Model Market Competitive Benchmarking And Dashboard

40. Upcoming Startups in the Market

41. Key Mergers And Acquisitions In The Artificial Intelligence (AI) Biocomputing Big Model Market

42. Artificial Intelligence (AI) Biocomputing Big Model Market High Potential Countries, Segments and Strategies

  • 42.1. Artificial Intelligence (AI) Biocomputing Big Model Market In 2030 - Countries Offering Most New Opportunities
  • 42.2. Artificial Intelligence (AI) Biocomputing Big Model Market In 2030 - Segments Offering Most New Opportunities
  • 42.3. Artificial Intelligence (AI) Biocomputing Big Model Market In 2030 - Growth Strategies
    • 42.3.1. Market Trend Based Strategies
    • 42.3.2. Competitor Strategies

43. Appendix

  • 43.1. Abbreviations
  • 43.2. Currencies
  • 43.3. Historic And Forecast Inflation Rates
  • 43.4. Research Inquiries
  • 43.5. The Business Research Company
  • 43.6. Copyright And Disclaimer